Pharmacists in Lawrence, Massachusetts


46 Pharmacists found in Lawrence
male pharmacist

Richard Paul Sidie


Pharmacist
128 Parker St, Lawrence, MA 01843
978-682-5122     978-794-3061

male pharmacist

Rithy Meas, RPH


Pharmacist
135 Broadway, Lawrence, MA 01840
978-725-3221    

male pharmacist

Mr. Robert M Gladstone, RPH


Pharmacist
150 Park St, Lawrence, MA 01841
978-686-4453    



female pharmacist

Ms. Robin Desmet, RPH


Pharmacist
128 Parker St, Lawrence, MA 01843
978-682-5122    

female pharmacist

Mrs. Rosaly V Ulrich, PHARM.D-RPH


Pharmacist
34 Haverhill St, Lawrence, MA 01841
978-857-3858    

female pharmacist

Roshni Pattabiraman, PHARMD


Pharmacist
34 Haverhill St, Lawrence, MA 01841
978-686-0090    

female pharmacist

Shama M Patel, PHARM D


Pharmacist
135 Broadway, Lawrence, MA 01840
978-725-3221    

male pharmacist

Dr. Shardul S Patel, PHARM.D., R.PH.


Pharmacist
34 Haverhill St, Lawrence, MA 01841
978-806-0024     978-494-4141

female pharmacist

Sothea Phaen, PHARM D


Pharmacist
1 General Street, Lawrence, MA 01842
978-683-4000    

female pharmacist

Mrs. Stacey Lynn Robert, RPH


Pharmacist
34 Haverhill St, Lawrence, MA 01841
978-688-1567    

male pharmacist

Steven Sordillo, RPH


Pharmacist
365 Essex St, Lawrence, MA 01840
978-682-5986     978-688-0328

female pharmacist

Trinh K Huynh, RPH


Pharmacist
150 Park St, Lawrence, MA 01841
978-689-6878    

female pharmacist

Dr. Vivian Vi Tuong Nguyen, PHARMD


Pharmacist
73a Winthrop Ave, Lawrence, MA 01843
978-686-0090    

female pharmacist

Yilisa Mota


Pharmacist
266 Broadway, Lawrence, MA 01841
978-688-5924     978-688-5929


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.